US 8350021
Conserved HBV and HCV sequences useful for gene silencing
granted A61KA61K38/00A61K48/00
Quick answer
US patent 8350021 (Conserved HBV and HCV sequences useful for gene silencing) held by Alnylam Pharmaceuticals, Inc. expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61K48/00, A61P, A61P1/16